The U.S. Food and Drug Administration (FDA) permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes....
Tandem is testing a system comprising its t:slim X2 insulin pump, its predictive low-glucose suspend algorithm and a Dexcom continuous glucose monitor in patients with Type 1 diabetes.